Sterling Biotech Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
-
|
P/BV
|
-
|
Book Value (Rs.)
|
-
|
52 Week High/Low (Rs.)
|
-
|
FV/ML
|
-
|
P/E(X)
|
-
|
Bookclosure
|
-
|
EPS (Rs.)
|
-
|
Div Yield (%)
|
-
|
|
(Rs. in Crs.)
Months | 12 | 15 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | -616.80 | -687.62 | -631.16 | -593.08 | -516.54 |
| | | | | |
Net CashFlow From Operating Activities | 0.95 | 67.03 | 255.89 | 171.87 | 811.25 |
Net Cash Used In Investing Activities | -49.28 | -84.45 | 17.20 | -314.82 | -811.62 |
Net Cash Used From Financing Activities | 48.62 | 16.40 | -272.92 | 142.60 | -3.79 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 0.29 | -1.02 | 0.17 | -0.35 | -4.15 |
Cash And Cash Equivalents Begin of Year | 16.64 | 17.66 | 17.49 | 17.83 | 21.99 |
Cash And Cash Equivalents End Of Year | 16.93 | 16.64 | 17.66 | 17.49 | 17.83 |